Eichenbaum Kenneth D. 4

What Happened Kenneth D. Eichenbaum, a director of FEMASYS Inc. (FEMY), was reported to have received 102,366 derivative instruments on March 19, 2026. The filing describes these as Series D-1 warrants (transaction code A — award/grant). The warrants have an initial exercise price of $0.58 per common share and are subject to adjustment under their terms; no cash value or immediate common stock was reported as received.

Key Details

• Transaction date: March 19, 2026 (Form 4 filed March 27, 2026).
• Security: 102,366 Series D-1 warrants (derivative), transaction code A (award/grant).
• Exercise price: $0.58 per share initially (adjustable per warrant terms).
• Ownership after transaction: Not disclosed in the provided summary filing.
• Notable footnotes:
  • F1: Warrants exercisable at $0.58 initially; exercise price subject to standard adjustments (splits, dividends, etc.).
  • F2: Exercise may be limited by Nasdaq Capital Market rules.
  • F3: Warrants were issued in a private placement as consideration under an Omnibus Amendment and Consent Agreement dated March 19, 2026.
• Timeliness: The Form 4 was filed eight days after the reported transaction date, which exceeds the typical 2-business-day Section 16 reporting window and may be considered late.

Context These are warrants (derivative securities) rather than immediate shares of common stock; to convert them into common stock the holder must exercise the warrants and pay the exercise price (subject to the stated limitations). Such awards can be part of corporate restructuring or compensation arrangements — the filing states they were issued as consideration related to an Omnibus Amendment and Consent Agreement. The filing reports the grant but does not indicate any immediate sale of shares or cashless exercise.